Woodline Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $62.6M | Sell |
|
|||||
2025
Q1 | $84.1M | Buy |
|
|||||
2024
Q4 | $67.9M | Sell |
|
|||||
2024
Q3 | $162M | Buy |
|
|||||
2024
Q2 | $69.1M | Buy |
|
|||||
2024
Q1 | $73.3M | Sell |
|
|||||
2023
Q4 | $119M | Buy |
|
|||||
2023
Q3 | $52.5M | Buy |
|
|||||
2023
Q2 | $50.7M | Buy |
|
|||||
2023
Q1 | $37.3M | Buy |
|
|||||
2022
Q4 | $34.7M | Sell |
|
|||||
2022
Q3 | $140M | Buy |
|
|||||
2022
Q2 | $25.8M | Sell |
|
|||||
2022
Q1 | $25.1M | Sell |
|
|||||
2021
Q4 | $47.2M | Sell |
|
|||||
2021
Q3 | $75.5M | Hold |
|
|||||
2021
Q2 | $74.4M | Sell |
|
|||||
2021
Q1 | $99.7M | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $11.8M | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $55.1M | Buy |
|